Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / G••••• S•••• D••••••••• M••••••••• •••••••• 7•

Y•••• Invests in G••••• S•••• D••••••••• M••••••••• •••••••• 7•, 2015) — Y•••• Partners (“Y••••”), a provider of mezzanine capital for middle market…

Platform acquisitionannouncedannounced Dec 7, 2015Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / dermatolog
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • B••• D••••Deal partnerconfirmed
    B••• D••••, Managing Partner of Y••••, added, “We are excited to partner with Dr. Becker, Dr. Zimmerman, the WCSL team, and Pouschine Cook to support the investment in G••••• State D•••••••••.
  • M••••••••• (D••••••• 7, 2015) — Y•••• Partners (“Y••••”), a provider of mezzanine capital for middle market private equity transactions, is pleased to announce that it has partnered with Pouschine Cook Capital Management (“Pouschine Cook”) and existing shareholders of Walnut Creek Skin & Laser, LLC
Advisory side
  • S••••• H••••• L••Legal adviserconfirmed
    Legal counsel for Y•••• was provided by S••••• H••••• L••.
Side not stated
Evidence
Y•••• Invests in G••••• S•••• D••••••••• M••••••••• •••••••• 7•, 2015) — Y•••• Partners (“Y••••”), a provider of mezzanine capital for middle market…
Y•••• Invests in G••••• S•••• D••••••••• M••••••••• •••••••• 7•, 2015) — Y•••• Partners (“ | Private Equity Intelligence | DFX